1.
Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients...
by Faergeman, Ole, MD, DMSc
The American journal of cardiology, 2009, Vol.104 (4), p.459-463
2.
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
by Strandberg, Timo E
The Lancet (British edition), 2004-08-28, Vol.364 (9436), p.771-777
3.
Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged <65 Versus ≥65 Years With Coronary Heart Disease (from the Incremental DEcre...
by Tikkanen, Matti J., MD, PhD
The American journal of cardiology, 2009, Vol.103 (5), p.577-582
4.
Comparative Effect of Atorvastatin (80 mg) Versus Simvastatin (20 to 40 mg) in Preventing Hospitalizations for Heart Failure in Patients With Previous Myocardial Infarction
by Strandberg, Timo E., MD, PhD
The American journal of cardiology, 2009, Vol.103 (10), p.1381-1385
5.
Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering
by Pedersen, Terje R
The American journal of cardiology, 2000, Vol.86 (3), p.257-262
6.
The atherosclerosis epidemic: Methodology, nosology, and clinical practice
by Faergeman, Ole
The American journal of cardiology, 2001, Vol.88 (2), p.4-7
7.
Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study
by Pedersen, Terje R
The American journal of cardiology, 2004, Vol.94 (6), p.720-724
8.
How can we identify low- and high-risk patients among unselected patients with possible acute coronary syndrome?
by Nielsen, Kirsten Melgaard, MD, PhD
The American journal of emergency medicine, 2007, Vol.25 (1), p.23-31
9.
The apolipoprotein E polymorphism in Greenland inuit in its global perspective
by GERDES, L. U
Human genetics, 1996, Vol.98 (5), p.546-550
10.
Are men carrying the apolipoprotein ε4- or ε2 allele less fertile than ε3ε3 genotypes ?
by GERDES, L. U
Human genetics, 1996, Vol.98 (2), p.239-242
11.
A Unique Pattern of apo(a) Polymorphism in an Isolated East Greenlandic Inuit (Eskimo) Population
by KLAUSEN, I. C
European journal of epidemiology, 1995-10-01, Vol.11 (5), p.563-568
12.
Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons
by Nielsen, K M
Journal of epidemiology and community health (1979), 2006-08, Vol.60 (8), p.721-728
13.
Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948
by HANSEN, P. S
Human genetics, 1993, Vol.91 (1), p.45-50
14.
Differences in apolipoprotein(a) polymorphism in West Greenland Eskimos and Caucasian Danes
by KLAUSEN, C
Human genetics, 1992, Vol.89 (4), p.384-388
15.
Lipoprotein(a) and Oxygen Free Radicals in Survivors of Acute Myocardial Infarction: Effects of Captopril
by Søgaard, Peter
Cardiology, 1996, Vol.87 (1), p.18-22
16.
Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol
by Vigholt-Sørensen, E
British Heart Journal, 1990-09, Vol.64 (3), p.186-189
17.
A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a)
by KLAUSEN, I. C
Human genetics, 1993, Vol.91 (2), p.193-195
18.
Placebo-Controlled Comparison of Captopril, Metoprolol, and Hydrochlorothiazide Therapy in Non - Insulin-Dependent Diabetic Patients With Primary Hypertension
by Gall, Mari-Anne
American journal of hypertension, 1992-05, Vol.5 (5-Pt-1), p.257-265
Filter electronic articles 18 Hits
Remove Filters
